BEATW
HeartBeam, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.01
−8.55%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | — | — | — |
| Cost of Revenue | 24.0K | — | — | — | — |
| Gross Profit | (24.0K) | — | — | — | — |
| Operating Expenses | |||||
| R&D Expense | 11.3M | 13.4M | 11.1M | 6.8M | 5.7M |
| SG&A Expense | 9.1M | 7.7M | 8.8M | 8.5M | 7.4M |
| General & Admin Expense | 6.7M | 7.7M | 8.8M | 8.5M | 7.4M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 20.4M | 21.1M | 19.9M | 15.3M | 13.0M |
| Cost and Expenses | 20.4M | 21.1M | 19.9M | 15.3M | 13.0M |
| Operating Income (EBIT) | (20.4M) | (21.1M) | (19.9M) | (15.3M) | (13.0M) |
| Non-Operating | |||||
| Interest Income | 110.0K | 122.0K | 446.0K | 675.0K | 66.0K |
| Interest Expense | — | — | — | — | 66.0K |
| Net Interest Income | 110.0K | 122.0K | 446.0K | 675.0K | — |
| Other Non-Op Income/Expense | 112.0K | 124.0K | 439.0K | 675.0K | 69.0K |
| Non-Operating Income (excl Interest) | (59.0K) | (124.0K) | (439.0K) | (675.0K) | (69.0K) |
| EBT (Pre-Tax Income) | (20.3M) | (21.0M) | (19.4M) | (14.6M) | (13.0M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (20.3M) | (21.0M) | (19.4M) | (14.6M) | (13.0M) |
| Earnings from Cont. Ops | (20.3M) | (21.0M) | (19.4M) | (14.6M) | (13.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (20.3M) | (21.0M) | (19.4M) | (14.6M) | (13.0M) |
| Per Share | |||||
| Basic EPS | ($0.52) | ($0.62) | ($0.73) | ($0.72) | ($1.59) |
| Diluted EPS | ($0.52) | ($0.62) | ($0.73) | ($0.72) | ($1.59) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 52.8M | 33.7M | 26.6M | 20.3M | 8.2M |
| Diluted Shares Outstanding | 52.8M | 33.7M | 26.6M | 20.3M | 8.2M |
| Profitability Metrics | |||||
| EBITDA | (20.3M) | (21.0M) | (19.4M) | 675.0K | 69.0K |
| D&A | 49.0K | 40.0K | 7.0K | 15.3M | 13.0M |
| EBIT | (20.3M) | (21.0M) | (19.4M) | (14.6M) | (13.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026